Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary - Bochtler, Tilmann; Reiling, Anna; Endris, Volker; Hielscher, Thomas; Volckmar, Anna-Lena; Neumann, Olaf; Kirchner, Martina; Budczies, Jan; Heukamp, Lukas C.; Leichsenring, Jonas; Allgäuer, Michael; Kazdal, Daniel; et al. (International journal of cancer, 2020)
Gesehen am 14.01.2021